Research on Antibiotics for Upper Respiratory Tract Infections in Children
Background on Pediatric Infections
Researchers have examined the effectiveness and safety of narrow versus broad-spectrum antibiotics for treating upper respiratory tract infections in children. Ear, sinus, and throat infections rank among the most frequently diagnosed ailments in this demographic, leading to significant antibiotic prescriptions. However, guidelines for their use vary widely. The American Academy of Pediatrics generally advocates for narrow-spectrum antibiotics, while the Infectious Diseases Society of America favors broad-spectrum options. This discrepancy arises partly from the evolving landscape of bacterial infections, influenced by the introduction of pneumococcal vaccinations, which may have shifted bacterial populations towards those resistant to narrow-spectrum antibiotics.
Goals and Concerns of Antibiotic Treatment
The primary objective of antibiotic treatment is to resolve infections. However, clinicians must be wary of the overuse of broad-spectrum antibiotics, which contributes to antibiotic resistance and can diminish patient quality of life due to heightened side effects.
Study Overview
Investigation by the Children’s Hospital of Philadelphia
Researchers at the Children’s Hospital of Philadelphia conducted a two-part cohort study to compare the effectiveness of broad-spectrum and narrow-spectrum antibiotics, alongside assessing patient-centered outcomes in children with acute respiratory tract infections. Findings from this research were published in the Journal of the American Medical Association.
Findings from the Efficacy Study
The first segment involved a retrospective analysis of 30,086 children prescribed oral antibiotics for acute upper respiratory tract infections, with 4,296 receiving broad-spectrum antibiotics. The study concluded that broad-spectrum antibiotics did not demonstrate statistically greater effectiveness than their narrow-spectrum counterparts. Treatment failure rates were comparable in both groups, while side effect reports were higher among patients on broad-spectrum antibiotics. These results endorse the preference for narrow-spectrum antibiotics in most cases.
Patient-Centered Outcomes Analysis
The second part of the study focused on a prospective observation of patient-centered outcomes related to antibiotic treatment. Researchers conducted interviews with patients or their guardians, inquiring about child suffering, attendance records, sleep disturbances, side effects, and the rate of symptom resolution. They utilized the Pediatric Quality of Life Inventory to evaluate these outcomes. Results indicated that children and guardians reported a higher incidence of side effects and a lower quality of life for those treated with broad-spectrum antibiotics. Other patient-centered outcomes were similar across both treatment groups, further supporting the preference for narrow-spectrum antibiotics.
Study Limitations
One limitation noted in this study is the potential for misdiagnosis, with some children possibly suffering from viral infections that did not necessitate antibiotic treatment, thereby skewing clinical outcome results. Additionally, the Pediatric Quality of Life Inventory, while utilized for assessing patient-centered outcomes, has not been validated specifically for acute respiratory tract infections.
Conclusion
In summary, broad-spectrum antibiotics have not proven to be more effective than narrow-spectrum antibiotics for treating acute upper respiratory tract infections in children. The former are associated with poorer quality of life scores and a higher incidence of side effects. This study reinforces the recommendation for using narrow-spectrum antibiotics in the majority of cases involving upper respiratory tract infections in children.
Author and Reference
Written by Jessica Caporuscio, PharmD.
Reference: Gerber JS, Ross RK, Bryan M, et al. Association of Broad- vs Narrow-Spectrum Antibiotics With Treatment Failure, Adverse Events, and Quality of Life in Children With Acute Respiratory Tract Infections. JAMA. 2017.